Latest News in the pharma Industry

Research & Development

ImmBio initiates First-in-Human studies of its novel pneumococcal vaccine, PnuBioVax

ImmBio initiates First-in-Human studies of its novel pneumococcal vaccine, PnuBioVax

11 Dec 2015

The PnuBioVax vaccine contains heat shock proteins and multiple antigens produced by a modified form of S. pneumoniae, leading to a mechanism of action which is expected to be strain-independent.

Read more 
AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new WCPR

AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new WCPR

11 Dec 2015

Read more 
Lilly and Merck expand immuno-oncology collaboration adding abemaciclib and Keytruda combination trial

Lilly and Merck expand immuno-oncology collaboration adding abemaciclib and Keytruda combination trial

10 Dec 2015

The collaboration has the potential to progress to Phase II trials in patients who have been diagnosed with either metastatic breast cancer or non-small cell lung cancer.

Read more 
New Phase III study of nintedanib in people with systemic sclerosis and lung fibrosis

New Phase III study of nintedanib in people with systemic sclerosis and lung fibrosis

9 Dec 2015

After demonstrating that nintedanib slows disease progression in idiopathic pulmonary fibrosis, Boehringer Ingelheim is expanding its research with nintedanib into other serious fibrotic lung conditions that arise in association with rare diseases such...

Read more 
FDA approves Kanuma for the treatment of patients with lysosomal acid lipase deficiency

FDA approves Kanuma for the treatment of patients with lysosomal acid lipase deficiency

9 Dec 2015

Kanuma is the first approved treatment in the US for patients suffering from LAL-D, a life-threatening and ultra-rare metabolic disorder.

Read more 
Novo Nordisk files for regulatory approval of faster-acting insulin aspart in the EU for the treatment of type 1 and 2 diabetes

Novo Nordisk files for regulatory approval of faster-acting insulin aspart in the EU for the treatment of type 1 and 2 diabetes

8 Dec 2015

The company intends to make faster-acting insulin aspart available in the prefilled delivery device FlexTouch.

Read more 
Daiichi Sankyo to reorganise its R&D structure

Daiichi Sankyo to reorganise its R&D structure

8 Dec 2015

Company's research subsidiary, U3 Pharma, to close.

Read more 
Stretchy hydrogel “Band-Aid” senses, lights up, delivers medicine

Stretchy hydrogel “Band-Aid” senses, lights up, delivers medicine

7 Dec 2015

Water-based “Band-Aid” senses temperatre, lights up, and delivers medicine to the skin.

Read more 
Novartis highlights new CTL019 Phase II data demonstrating 93% complete remission in pediatric patients with r/r ALL

Novartis highlights new CTL019 Phase II data demonstrating 93% complete remission in pediatric patients with r/r ALL

7 Dec 2015

55 of 59 patients experienced complete remissions in a single-arm study of the largest investigational CART therapy in children and young adults.

Read more 
GlycoMimetics poster shows GMI-1271 reverses drug resistance in multiple myeloma models

GlycoMimetics poster shows GMI-1271 reverses drug resistance in multiple myeloma models

6 Dec 2015

GlycoMimetics to initiate myeloma trial in mid-2016.

Read more 
Amgen's first biosimilar marketing authorization application submitted to EMA for ABP 501

Amgen's first biosimilar marketing authorization application submitted to EMA for ABP 501

4 Dec 2015

Supported by Phase III studies in moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.

Read more 
Propeller Health announces development agreement and R&D collaboration with GSK to develop a digital sensor for the Ellipta inhaler

Propeller Health announces development agreement and R&D collaboration with GSK to develop a digital sensor for the Ellipta inhaler

1 Dec 2015

Collaboration reinforces Propeller Health's leadership in respiratory digital health and creates a joint opportunity to advance treatment of respiratory disease through digital innovation.

Read more